CL2014000172A1 - Composicion en spray que comprende a) un portador de oxigeno, tal como hemoglobina o mioglobina; y b) al menos un ingrediente adicional; metodo para preparar la composicion; proceso para purificar un portador de oxigeno; y su uso para el tratamiento externo de heridas. - Google Patents

Composicion en spray que comprende a) un portador de oxigeno, tal como hemoglobina o mioglobina; y b) al menos un ingrediente adicional; metodo para preparar la composicion; proceso para purificar un portador de oxigeno; y su uso para el tratamiento externo de heridas.

Info

Publication number: CL2014000172A1
Authority: CL; Chile
Prior art keywords: oxygen carrier; composition; myoglobin; hemoglobin; wounds
Prior art date: 2011-07-23

Application number

CL2014000172A

Other languages

English (en)

Inventor

Michael Sander

Harald Potzschke

Original Assignee

Sastomed Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2011-07-23

Filing date

2014-01-22

Publication date

2014-08-29

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46604251&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2014000172(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2014-01-22 Application filed by Sastomed Gmbh filed Critical Sastomed Gmbh

2014-08-29 Publication of CL2014000172A1 publication Critical patent/CL2014000172A1/es

Links

QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 title 2
238000000034 method Methods 0.000 title 2
239000000203 mixture Substances 0.000 title 2
229910052760 oxygen Inorganic materials 0.000 title 2
239000001301 oxygen Substances 0.000 title 2
102000001554 Hemoglobins Human genes 0.000 title 1
108010054147 Hemoglobins Proteins 0.000 title 1
102000036675 Myoglobin Human genes 0.000 title 1
108010062374 Myoglobin Proteins 0.000 title 1
206010052428 Wound Diseases 0.000 title 1
208000027418 Wounds and injury Diseases 0.000 title 1
239000004615 ingredient Substances 0.000 title 1
239000007921 spray Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0028—Polypeptides; Proteins; Degradation products thereof
- A61L26/0047—Specific proteins or polypeptides not covered by groups A61L26/0033 - A61L26/0042
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/41—Porphyrin- or corrin-ring-containing peptides
- A61K38/42—Haemoglobins; Myoglobins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/0066—Medicaments; Biocides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/0076—Sprayable compositions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
- A61M1/3403—Regulation parameters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M35/00—Devices for applying media, e.g. remedies, on the human body
- A61M35/003—Portable hand-held applicators having means for dispensing or spreading integral media
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/795—Porphyrin- or corrin-ring-containing peptides
- C07K14/805—Haemoglobins; Myoglobins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/412—Tissue-regenerating or healing or proliferative agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2202/00—Special media to be introduced, removed or treated
- A61M2202/04—Liquids
- A61M2202/0413—Blood
- A61M2202/0429—Red blood cells; Erythrocytes
- A61M2202/0433—Free haemoglobin
- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F04—POSITIVE - DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS FOR LIQUIDS OR ELASTIC FLUIDS
- F04C—ROTARY-PISTON, OR OSCILLATING-PISTON, POSITIVE-DISPLACEMENT MACHINES FOR LIQUIDS; ROTARY-PISTON, OR OSCILLATING-PISTON, POSITIVE-DISPLACEMENT PUMPS
- F04C2270/00—Control; Monitoring or safety arrangements
- F04C2270/04—Force
- F04C2270/041—Controlled or regulated

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Heart & Thoracic Surgery (AREA)
Epidemiology (AREA)
Anesthesiology (AREA)
Biomedical Technology (AREA)
Hematology (AREA)
Materials Engineering (AREA)
Medicinal Chemistry (AREA)
Vascular Medicine (AREA)
Organic Chemistry (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
General Chemical & Material Sciences (AREA)
Dermatology (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

CL2014000172A 2011-07-23 2014-01-22 Composicion en spray que comprende a) un portador de oxigeno, tal como hemoglobina o mioglobina; y b) al menos un ingrediente adicional; metodo para preparar la composicion; proceso para purificar un portador de oxigeno; y su uso para el tratamiento externo de heridas. CL2014000172A1 (es)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP11006057.1A EP2550973B1 (en)	2011-07-23	2011-07-23	Wound spray

Publications (1)

Publication Number	Publication Date
CL2014000172A1 true CL2014000172A1 (es)	2014-08-29

Family

ID=46604251

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CL2014000172A CL2014000172A1 (es)	2011-07-23	2014-01-22	Composicion en spray que comprende a) un portador de oxigeno, tal como hemoglobina o mioglobina; y b) al menos un ingrediente adicional; metodo para preparar la composicion; proceso para purificar un portador de oxigeno; y su uso para el tratamiento externo de heridas.

Country Status (21)

Country	Link
US (3)	US10646613B2 (es)
EP (2)	EP2550973B1 (es)
JP (1)	JP5995970B2 (es)
KR (1)	KR101900991B1 (es)
CN (2)	CN108752468B (es)
AU (1)	AU2012289237B2 (es)
BR (1)	BR112014001309B1 (es)
CA (1)	CA2842487C (es)
CL (1)	CL2014000172A1 (es)
CO (1)	CO6940380A2 (es)
EA (1)	EA030017B1 (es)
ES (2)	ES2432075T3 (es)
HU (1)	HUE029928T2 (es)
IL (1)	IL230160A (es)
MX (1)	MX2014000900A (es)
MY (1)	MY165035A (es)
PE (1)	PE20141577A1 (es)
PL (2)	PL2550973T3 (es)
UA (1)	UA113290C2 (es)
WO (1)	WO2013013799A1 (es)
ZA (1)	ZA201400078B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP2614833A1 (en) *	2012-01-13	2013-07-17	SastoMed GmbH	Scarring reducing wound treatment
US10729748B2 (en)	2012-01-13	2020-08-04	Mölnlycke Health Care Ab	Scarring reducing wound treatment
DE102013014651A1 (de) *	2013-09-03	2015-03-05	Sanguibiotech Gmbh	Zubereitungen zur verbesserten Gewebe-Oxygenierung durch peritoneale Beatmung
EP3421044A1 (en)	2017-06-26	2019-01-02	SastoMed GmbH	Oxygen carriers for the treatment of skin indispositions
EP3655019A4 (en)	2017-07-18	2021-04-21	Virtech Bio, Inc.	BLOOD SUBSTITUTES INCLUDING HEMOGLOBIN AND METHODS OF MANUFACTURING
GB201818811D0 (en)	2018-11-19	2019-01-02	Smith & Nephew	Method of immobilising a protein on a substrate
US11506658B2 (en)	2019-04-24	2022-11-22	Progenitec, Inc.	System for analysis of body fluids and wound-associated biomolecules
CN113609885A (zh) *	2020-06-22	2021-11-05	王英婷	自适应舱门开关控制系统及方法
CN116036247B (zh) *	2023-02-03	2024-04-05	江中药业股份有限公司	用于抑制炎症反应、促进血管生成及伤口愈合的组合物及应用
CN117100905A (zh) *	2023-10-25	2023-11-24	润方（北京）生物医药研究院有限公司	促进伤口愈合的敷料
CN119033998B (zh) *	2024-11-04	2025-01-24	润方（北京）生物医药研究院有限公司	一种伤口敷料及其制备方法与应用

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE441893C (de)		1927-03-14	Max Mueller	Selbstdockendes Schwimmdock mit dreiteiligem Bodenkasten
DE357665C (de)	1919-05-08	1922-08-29	Felten & Guilleaume Carlswerk	Isoliermasse zur Abdichtung elektrischer Leitungen und Kabel
DE371435C (de)	1921-05-15	1923-03-15	Norske Molybdenprodukter A S	Verfahren zur Reduktion von Molybdaen-Schwefelverbindungen
DE384110C (de)	1922-09-19	1923-11-03	Fallert & Co A G	Vorrichtung zum Zentrieren der Spindel einer Massewalze in der Giessflasche
US2527210A (en)	1944-01-25	1950-10-24	John O Bower	Hemoglobin solution and method
DE1970137U (de)	1967-04-01	1967-10-12	Guenter Friebe	Satz kombinierbarer moebel-bauelemente.
DE3320752A1 (de)	1983-06-09	1984-12-13	Wolfgang Prof. Dr.Dr. 6500 Mainz Barnikol	Lumineszierende schichten zur verwendung in vorrichtungen zur bestimmung der sauerstoffkonzentration in gasen und dergleichen durch messung der lumineszensverringerung
US4776991A (en) *	1986-08-29	1988-10-11	The United States Of America As Represented By The Secretary Of The Navy	Scaled-up production of liposome-encapsulated hemoglobin
DE3714351A1 (de)	1987-04-29	1988-11-17	Barnikol Wolfgang	Verfahren zur modifikation, insbesondere zur polymerisation von haemoglobin in vitro
GB8710598D0 (en) *	1987-05-05	1987-06-10	Star Medical Diagnostics Ltd	Hemoglobin based blood substitute
DE3841105C2 (de)	1988-12-07	1994-09-01	Wolfgang Karl Richard Barnikol	Verfahren zur Aufreinigung und Modifikation von polymerisiertem Hämoglobin
US5840851A (en) *	1993-07-23	1998-11-24	Plomer; J. Jeffrey	Purification of hemoglobin
DE4418937C2 (de)	1994-02-28	2003-07-17	Roesler Draht Ag	Klappgelenkmatte
US5476764A (en) *	1994-09-16	1995-12-19	The Regents Of The University Of California	Method using CO for extending the useful shelf-life of refrigerated red blood cells
AU705225B2 (en)	1995-03-23	1999-05-20	Biopure Corporation	Stable polymerized hemoglobin blood substitute
WO1997015313A1 (en)	1995-10-26	1997-05-01	Baxter International Inc.	Therapeutic use of hemoglobin in promoting wound healing
DE19701037A1 (de)	1997-01-15	1998-07-16	Sanguibiotech Ag	Mit Schutzliganden der Sauerstoffbindungsstellen versehene Hämoglobine als künstliche Sauerstoffträger zur direkten biologisch-medizinischen Anwendung und Verfahren zu ihrer Herstellung
EP0854151A1 (de)	1997-01-20	1998-07-22	SanguiBioTech AG	Verfahren zur Gewinnung einheitlicher Fraktionen hyperpolymerer Hämoglobine
DE19933275A1 (de) *	1999-07-14	2001-01-18	Fresenius Ag	Verwendung von Hämoglobin-Derivaten zur Bestimmung des Plasma- und/oder Blutvolumens
EP1233986A4 (en)	1999-11-12	2003-01-02	Baxter Biotech Tech Sarl	HEMOGLOBIN COMPOSITIONS WITH REDUCED SIDE EFFECTS
DE10031744A1 (de)	2000-06-29	2002-01-17	Sanguibio Tech Ag	Mit Blutplasma verträgliche, vernetzte und mit Polyalkylenoxiden konjugierte Säugetierhämoglobine als künstliche medizinische Sauerstoffträger, ihre Herstellung und ihre Verwendung
DE10031741A1 (de) *	2000-06-29	2002-01-17	Sanguibio Tech Ag	Einen Sauerstoffträger, ausgewählt aus Hämoglobin oder Hämoglobin- und Myoglobin-enthaltende Zubereitung als Externum zur natürlichen Regeneration der Haut bei Sauerstoff-Mangel
DE10031740A1 (de)	2000-06-29	2002-02-14	Sanguibio Tech Ag	Künstliche Sauerstoffträger aus vernetztem modifizierten Human- oder Schweinehämoglobin mit verbesserten Eigenschaften, Verfahren zu ihrer technisch einfachen Herstellung aus gereinigtem Material in hohen Ausbeuten, sowie deren Verwendung
DE10031742A1 (de)	2000-06-29	2002-01-17	Sanguibio Tech Ag	Verfahren zur Herstellung künstlicher Sauerstoffträger aus kovalent vernetzten Hämoglobinen mit verbesserten funktionellen Eigenschaften durch Vernetzung in Anwesenheit chemisch nicht reagierender Effektoren der Sauerstoffaffinität der Hämoglobine
US6518010B2 (en) *	2001-02-28	2003-02-11	Biopure Corporation	Use of defibrinated blood for manufacture of a hemoglobin-based oxygen carrier
DE10212321A1 (de) *	2002-03-20	2003-10-09	Sanguibio Tech Ag	Verwendung eines oder mehrerer von Plasma und Zellwandbestandteilen befreiten natürlichen oder modifizierten Sauerstoffbinder zur externen Behandlung offener, insbesondere chronischer Wunden
IL149611A (en)	2002-05-13	2011-07-31	Safetin Ltd	Method for extended storage of viable and pathogen-safe blood and blood components using carbon monoxide
US20080248012A1 (en)	2004-01-29	2008-10-09	Keio University	Erythrocyte Function Modifying Substance
CN1786018B (zh) *	2005-12-12	2011-06-22	天津协和生物科技发展有限公司	高纯度血红蛋白的分离纯化与病毒灭活工艺
WO2008034138A1 (en) *	2006-09-15	2008-03-20	The Ohio State University Research Foundation	Methods and compositions for the topical oxygenation of hypoxic tissue
FR2917292B1 (fr) *	2007-06-18	2014-06-13	Centre Nat Rech Scient	Utilisation d'une hemoglobine pour la preparation de pansements, et pansements ainsi prepares
DK3266463T3 (da) *	2009-06-09	2024-01-08	Prolong Pharmaceuticals Llc	Hæmoglobinsammensætninger
CN101948630B (zh) *	2010-09-10	2013-02-27	合肥工业大学	利用畜禽血液制备碳氧血红蛋白的方法

2011
- 2011-07-23 PL PL11006057T patent/PL2550973T3/pl unknown
- 2011-07-23 ES ES11006057T patent/ES2432075T3/es active Active
- 2011-07-23 EP EP11006057.1A patent/EP2550973B1/en active Active
2012
- 2012-07-23 UA UAA201401698A patent/UA113290C2/uk unknown
- 2012-07-23 ES ES12743076.7T patent/ES2593530T3/es active Active
- 2012-07-23 EA EA201490319A patent/EA030017B1/ru unknown
- 2012-07-23 CN CN201810501606.1A patent/CN108752468B/zh active Active
- 2012-07-23 MX MX2014000900A patent/MX2014000900A/es active IP Right Grant
- 2012-07-23 CN CN201280036457.7A patent/CN103781488A/zh active Pending
- 2012-07-23 JP JP2014521979A patent/JP5995970B2/ja not_active Expired - Fee Related
- 2012-07-23 WO PCT/EP2012/003086 patent/WO2013013799A1/en not_active Ceased
- 2012-07-23 PL PL12743076T patent/PL2734223T3/pl unknown
- 2012-07-23 MY MYPI2014000201A patent/MY165035A/en unknown
- 2012-07-23 AU AU2012289237A patent/AU2012289237B2/en active Active
- 2012-07-23 HU HUE12743076A patent/HUE029928T2/en unknown
- 2012-07-23 CA CA2842487A patent/CA2842487C/en active Active
- 2012-07-23 US US14/131,022 patent/US10646613B2/en active Active
- 2012-07-23 KR KR1020147000816A patent/KR101900991B1/ko active Active
- 2012-07-23 BR BR112014001309-8A patent/BR112014001309B1/pt active IP Right Grant
- 2012-07-23 EP EP12743076.7A patent/EP2734223B1/en active Active
- 2012-07-23 PE PE2014000111A patent/PE20141577A1/es not_active Application Discontinuation
2013
- 2013-12-25 IL IL230160A patent/IL230160A/en active IP Right Grant
2014
- 2014-01-06 ZA ZA2014/00078A patent/ZA201400078B/en unknown
- 2014-01-21 CO CO14011086A patent/CO6940380A2/es unknown
- 2014-01-22 CL CL2014000172A patent/CL2014000172A1/es unknown
2016
- 2016-04-21 US US15/134,764 patent/US10471175B2/en active Active
2020
- 2020-03-31 US US16/835,662 patent/US11116868B2/en active Active

Also Published As

Publication number	Publication date
EP2734223B1 (en)	2016-08-31
ES2593530T3 (es)	2016-12-09
KR20140045498A (ko)	2014-04-16
CA2842487A1 (en)	2013-01-31
IL230160A (en)	2017-12-31
CO6940380A2 (es)	2014-05-09
US20140221944A1 (en)	2014-08-07
CN108752468A (zh)	2018-11-06
EP2550973A1 (en)	2013-01-30
WO2013013799A1 (en)	2013-01-31
MY165035A (en)	2018-02-28
CA2842487C (en)	2021-02-02
HUE029928T2 (en)	2017-04-28
US10471175B2 (en)	2019-11-12
US10646613B2 (en)	2020-05-12
EA030017B1 (ru)	2018-06-29
PL2550973T3 (pl)	2014-03-31
PL2734223T3 (pl)	2017-09-29
BR112014001309B1 (pt)	2020-02-18
MX2014000900A (es)	2014-05-30
ES2432075T3 (es)	2013-11-29
KR101900991B1 (ko)	2018-09-20
CN103781488A (zh)	2014-05-07
AU2012289237A1 (en)	2014-01-16
EP2550973B1 (en)	2013-08-28
US11116868B2 (en)	2021-09-14
US20200230285A1 (en)	2020-07-23
EP2734223A1 (en)	2014-05-28
JP5995970B2 (ja)	2016-09-21
EA201490319A1 (ru)	2014-05-30
CN108752468B (zh)	2023-06-30
NZ619177A (en)	2016-04-29
PE20141577A1 (es)	2014-11-29
US20160228602A1 (en)	2016-08-11
ES2432075T8 (es)	2014-12-29
UA113290C2 (xx)	2017-01-10
HK1177902A1 (en)	2013-08-30
BR112014001309A2 (pt)	2017-02-21
JP2014521615A (ja)	2014-08-28
ZA201400078B (en)	2015-11-25
AU2012289237B2 (en)	2017-03-16

Publication	Publication Date	Title
CL2014000630A1 (es)	2014-11-07	Una composicion que comprende 1) un compuesto derivado de nucleosido denominado como compuesto 10 y 2) un compuesto derivado de acido 5-tiofeno-2-carboxilico denominado como compuesto 5 o un compuesto derivado del ester metilico del acido carbamico denominado como compuesto 6; y su uso para el tratamiento profilactico o terapeutico de una infeccion por vhc.
LT2916860T (lt)	2020-07-10	Diabeto gydymui skirta kompozicija, apimanti oksintomodulino analogą
BR112015002541A2 (pt)	2017-12-05	composto, composição farmacêutica, uso de um composto, e, método para tratamento de hcv em um paciente.
CL2015001442A1 (es)	2015-08-28	Metodo para tratar enfermedades pulmonares que comprende el uso de compuestos derivados del acido obeticolico.
CL2013001428A1 (es)	2014-06-27	Compuesto que inhibe la actividad del virus de la hepatitis c (hcv); composición farmacéutica que comprende el compuesto; método de tratamiento de hepatitis c.
MX2013005407A (es)	2013-07-03	5-halopirazolcarboxamidas.
CL2014000311A1 (es)	2014-10-17	Compuestos derivados de benzotiazepinas sustituidas; composicion farmaceutica que los contiene; y su uso para el tratamiento o profilaxis de la infeccion del virus sincicial respiratorio.
BR112014010179A2 (pt)	2017-04-25	composto, composição farmacêutica, uso de um composto, e, método para a profilaxia ou tratamento de um estado ou condição
CL2015001065A1 (es)	2015-10-02	Compuestos tolilo sustituidos; composición fungicida que los comprende; y método de control de enfermedades causadas por patógenos fúngicos en plantas.
CL2013003372A1 (es)	2014-07-25	Compuestos derivados de espiro-[1,3]-oxacinas y espiro-[1,4]-oxacepinas, inhibidores de bace1 y/o bace2; composicion farmaceutica; procedimiento para prepararlos; y su uso en el tratamiento y/o la profilaxis de la enfermedad de alzheimer y diabetes.
CL2014000024A1 (es)	2014-11-21	Composición que comprende un polipéptido quimérico que tiene actividad de factor viii, y uso de la composición para prevenir, disminuir o tratar una afección de sangrado, tal como hemofilia.
CL2014000470A1 (es)	2014-10-17	Compuestos derivados del acido 2-oxo-piridin-3-carboxilico; composicion farmaceutica; combinacion; y su uso para tratar o mejorar una infeccion bacteriana.
PH12015501887B1 (en)	2015-12-07	Novel bacteriophage and antibacterial composition comprising the same
WO2012125832A3 (en)	2012-11-08	Antimicrobial agents
CR20140263A (es)	2014-07-23	Composicion herbicida que contiene acido de 4-amino-3-cloro-6-(-4-cloro-2-fluor-3-metoxifenil) piridina-2-carboxilico, o los derivados del mismo y fluroxipir, o los derivados del mismo
CO6300844A2 (es)	2011-07-21	Dihidropirazolonas sustituidas como inhibidores de hif-propil-4-hidroxilasa
CL2015000254A1 (es)	2015-10-16	Vesículas que comprenden factor de crecimiento epidermico (egf); proceso de preparación; composición farmacéutica que las comprende; y uso para tratar heridas complejas .
MX2013004570A (es)	2013-05-17	Mezclas fungicidas de penflufen.
BR112013024974A2 (pt)	2016-09-06	composto, composição farmacêutica, método para o tratamento de infecções virais, e, processo para preparar um composto
DOP2016000253A (es)	2016-10-31	Nuevos compuestos
CL2016002879A1 (es)	2017-02-24	Composiciones farmacéuticas para tratar enfermedades infecciosas
LT2939665T (lt)	2019-07-25	Farmacinė kompozicija, skirta živ infekcijų gydymui
CL2014003325A1 (es)	2015-04-24	Compuestos derivados de difluoro-hexahidro-ciclopentaoxacinilos y difluoro-hexahidro-benzooxacinilos, inhibidores de bace 1; composicion farmaceutica; y su uso en el tratamiento de enfermedades con niveles elevados de beta-amiloide, tal como la enfermedad de alzheimer
PE20150167A1 (es)	2015-02-07	(r)-nifuratel, su uso para el tratamiento de las infecciones y sintesis de (r) y (s)-nifuratel
CL2014002845A1 (es)	2015-01-30	Compuestos derivados de pirazol inhibidores de sglt1; metodo para tratar la diabetes; composicion farmaceutica; uso del compuesto para el tratamiento de la diabetes tipo 1 y tipo 2.